CX-2051 treatment demonstrated responses in patients with advanced, late-line colorectal cancer, according to interim data ...

Researchers followed patients for years and found that the risk of dying from prostate cancer depended on how aggressive the ...

The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met ...

Even after many cancer-free years, the fear of recurrence still lingers, and many long-term survivors struggle to keep those ...

The FDA approved Welireg for adult and pediatric patients 12 and older with locally advanced, unresectable or metastatic ...

The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and ...

After walking alone in Chicago’s Cancer Survivor’s Walk, I found strength, healing and a renewed commitment to live fully and authentically — starting now.

I share how I survived multiple myeloma, painful spine fractures and years of recovery to reclaim my independence and ...

Dr. Hyman B. Muss discusses the unique challenges that older patients with breast cancer face during and after treatment for ...

Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate ...

Treatment with Perjeta, Herceptin and chemotherapy post-surgery led to a significant overall survival benefit in ...

Living with stage 4 kidney cancer has taught me to embrace the present, cherish connection and find gratitude each day in ...